Loading…
Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii
Very few studies have examined drug susceptibility of , and they involve a limited number of strains. The purpose of this study was to determine drug susceptibility profiles of isolates representing a spectrum of species genotypes (subtypes) with two different methodologies, i.e., broth microdilutio...
Saved in:
Published in: | Antimicrobial agents and chemotherapy 2018-04, Vol.62 (4) |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-a418t-d91cd123a725f15bb245dda0c87402fb0b9a51245e1175e8976c566537ebda5f3 |
---|---|
cites | cdi_FETCH-LOGICAL-a418t-d91cd123a725f15bb245dda0c87402fb0b9a51245e1175e8976c566537ebda5f3 |
container_end_page | |
container_issue | 4 |
container_start_page | |
container_title | Antimicrobial agents and chemotherapy |
container_volume | 62 |
creator | Bakuła, Zofia Modrzejewska, Magdalena Pennings, Lian Proboszcz, Małgorzata Safianowska, Aleksandra Bielecki, Jacek van Ingen, Jakko Jagielski, Tomasz |
description | Very few studies have examined drug susceptibility of
, and they involve a limited number of strains. The purpose of this study was to determine drug susceptibility profiles of
isolates representing a spectrum of species genotypes (subtypes) with two different methodologies, i.e., broth microdilution and Etest assays. To confirm drug resistance, drug target genes were sequenced. A collection of 85
isolates, including representatives of eight different subtypes (I to VI, I/II, and IIB) from eight countries, was used. Drug susceptibility against 13 and 8 antimycobacterial agents was tested by using broth microdilution and Etest, respectively. For drug-resistant or high-MIC isolates, eight structural genes (
,
,
,
,
,
,
, and
) and one regulatory region (
) were PCR amplified and sequenced in the search for resistance-associated mutations. All isolates tested were susceptible to rifampin (RIF), amikacin (AMK), co-trimoxazole (SXT), rifabutin (RFB), moxifloxacin (MXF), and linezolid (LZD) according to the microdilution method. Resistance to ethambutol (EMB), ciprofloxacin (CIP), and clarithromycin (CLR) was found in 83 (97.7%), 17 (20%), and 1 (1.2%) isolate, respectively. The calculated concordance between the Etest and dilution method was 22.6% for AMK, 4.8% for streptomycin (STR), 3.2% for CLR, and 1.6% for RIF. For EMB, INH, and SXT, not even a single MIC value determined by one method equaled that by the second method. The only mutations disclosed were A2266C transversion at the
gene (CLR-resistant strain) and A128G transition at the
gene (strain with STR MIC of >64 mg/liter). In conclusion, eight drugs, including RIF, CLR, AMK, SXT, RFB, MXF, LZD, and ethionamide (ETO), showed high
activity against
isolates. Discrepancies of the results between the reference microdilution method and Etest preclude the use of the latter for drug susceptibility determination in
Drug resistance in
may have different genetic determinants than resistance to the same drugs in
. |
doi_str_mv | 10.1128/AAC.01788-17 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5913922</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2002210037</sourcerecordid><originalsourceid>FETCH-LOGICAL-a418t-d91cd123a725f15bb245dda0c87402fb0b9a51245e1175e8976c566537ebda5f3</originalsourceid><addsrcrecordid>eNp1kU1v1DAQhi0Eokvhxhn5CBIpHieO4wvSagsFqRWIj7M1cZzFJbEX26m0_x6321b0wMnjmWfe0cxLyEtgJwC8e7deb04YyK6rQD4iK2Cqq1qh2sdkxVjbVk3HmiPyLKVLVv5CsafkiKumli2XK2JO47Kl35dk7C673k0u7-nXGMYS-S1FP9Az6212hp7abOPsPPqcaBjpTec3m1zK6I2lztOLvQk9msK5Zaa_0SdMzj0nT0ackn1x-x6Tnx8__Nh8qs6_nH3erM8rbKDL1aDADMBrlFyMIPqeN2IYkJlONoyPPesVCihJCyCF7ZRsjWhbUUvbDyjG-pi8P-juln62g7E-R5z0LroZ414HdPphxbtfehuutFBQK86LwOtbgRj-LDZlPbtymGlCb8OSNGeMc2CslgV9e0BNDClFO96PAaavfdHFF33ji4Zr_M0BxzRzfRmW6Msl_se--neNe-E70-q_P1iW5g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2002210037</pqid></control><display><type>article</type><title>Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii</title><source>PubMed Central Free</source><source>American Society for Microbiology Journals</source><creator>Bakuła, Zofia ; Modrzejewska, Magdalena ; Pennings, Lian ; Proboszcz, Małgorzata ; Safianowska, Aleksandra ; Bielecki, Jacek ; van Ingen, Jakko ; Jagielski, Tomasz</creator><creatorcontrib>Bakuła, Zofia ; Modrzejewska, Magdalena ; Pennings, Lian ; Proboszcz, Małgorzata ; Safianowska, Aleksandra ; Bielecki, Jacek ; van Ingen, Jakko ; Jagielski, Tomasz</creatorcontrib><description>Very few studies have examined drug susceptibility of
, and they involve a limited number of strains. The purpose of this study was to determine drug susceptibility profiles of
isolates representing a spectrum of species genotypes (subtypes) with two different methodologies, i.e., broth microdilution and Etest assays. To confirm drug resistance, drug target genes were sequenced. A collection of 85
isolates, including representatives of eight different subtypes (I to VI, I/II, and IIB) from eight countries, was used. Drug susceptibility against 13 and 8 antimycobacterial agents was tested by using broth microdilution and Etest, respectively. For drug-resistant or high-MIC isolates, eight structural genes (
,
,
,
,
,
,
, and
) and one regulatory region (
) were PCR amplified and sequenced in the search for resistance-associated mutations. All isolates tested were susceptible to rifampin (RIF), amikacin (AMK), co-trimoxazole (SXT), rifabutin (RFB), moxifloxacin (MXF), and linezolid (LZD) according to the microdilution method. Resistance to ethambutol (EMB), ciprofloxacin (CIP), and clarithromycin (CLR) was found in 83 (97.7%), 17 (20%), and 1 (1.2%) isolate, respectively. The calculated concordance between the Etest and dilution method was 22.6% for AMK, 4.8% for streptomycin (STR), 3.2% for CLR, and 1.6% for RIF. For EMB, INH, and SXT, not even a single MIC value determined by one method equaled that by the second method. The only mutations disclosed were A2266C transversion at the
gene (CLR-resistant strain) and A128G transition at the
gene (strain with STR MIC of >64 mg/liter). In conclusion, eight drugs, including RIF, CLR, AMK, SXT, RFB, MXF, LZD, and ethionamide (ETO), showed high
activity against
isolates. Discrepancies of the results between the reference microdilution method and Etest preclude the use of the latter for drug susceptibility determination in
Drug resistance in
may have different genetic determinants than resistance to the same drugs in
.</description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/AAC.01788-17</identifier><identifier>PMID: 29437627</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Antitubercular Agents ; Mycobacterium kansasii ; Mycobacterium tuberculosis ; Susceptibility</subject><ispartof>Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4)</ispartof><rights>Copyright © 2018 American Society for Microbiology.</rights><rights>Copyright © 2018 American Society for Microbiology. 2018 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a418t-d91cd123a725f15bb245dda0c87402fb0b9a51245e1175e8976c566537ebda5f3</citedby><cites>FETCH-LOGICAL-a418t-d91cd123a725f15bb245dda0c87402fb0b9a51245e1175e8976c566537ebda5f3</cites><orcidid>0000-0003-3343-6823 ; 0000-0002-0581-2003</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.asm.org/doi/pdf/10.1128/AAC.01788-17$$EPDF$$P50$$Gasm2$$H</linktopdf><linktohtml>$$Uhttps://journals.asm.org/doi/full/10.1128/AAC.01788-17$$EHTML$$P50$$Gasm2$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3188,27924,27925,52751,52752,52753,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29437627$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bakuła, Zofia</creatorcontrib><creatorcontrib>Modrzejewska, Magdalena</creatorcontrib><creatorcontrib>Pennings, Lian</creatorcontrib><creatorcontrib>Proboszcz, Małgorzata</creatorcontrib><creatorcontrib>Safianowska, Aleksandra</creatorcontrib><creatorcontrib>Bielecki, Jacek</creatorcontrib><creatorcontrib>van Ingen, Jakko</creatorcontrib><creatorcontrib>Jagielski, Tomasz</creatorcontrib><title>Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii</title><title>Antimicrobial agents and chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Very few studies have examined drug susceptibility of
, and they involve a limited number of strains. The purpose of this study was to determine drug susceptibility profiles of
isolates representing a spectrum of species genotypes (subtypes) with two different methodologies, i.e., broth microdilution and Etest assays. To confirm drug resistance, drug target genes were sequenced. A collection of 85
isolates, including representatives of eight different subtypes (I to VI, I/II, and IIB) from eight countries, was used. Drug susceptibility against 13 and 8 antimycobacterial agents was tested by using broth microdilution and Etest, respectively. For drug-resistant or high-MIC isolates, eight structural genes (
,
,
,
,
,
,
, and
) and one regulatory region (
) were PCR amplified and sequenced in the search for resistance-associated mutations. All isolates tested were susceptible to rifampin (RIF), amikacin (AMK), co-trimoxazole (SXT), rifabutin (RFB), moxifloxacin (MXF), and linezolid (LZD) according to the microdilution method. Resistance to ethambutol (EMB), ciprofloxacin (CIP), and clarithromycin (CLR) was found in 83 (97.7%), 17 (20%), and 1 (1.2%) isolate, respectively. The calculated concordance between the Etest and dilution method was 22.6% for AMK, 4.8% for streptomycin (STR), 3.2% for CLR, and 1.6% for RIF. For EMB, INH, and SXT, not even a single MIC value determined by one method equaled that by the second method. The only mutations disclosed were A2266C transversion at the
gene (CLR-resistant strain) and A128G transition at the
gene (strain with STR MIC of >64 mg/liter). In conclusion, eight drugs, including RIF, CLR, AMK, SXT, RFB, MXF, LZD, and ethionamide (ETO), showed high
activity against
isolates. Discrepancies of the results between the reference microdilution method and Etest preclude the use of the latter for drug susceptibility determination in
Drug resistance in
may have different genetic determinants than resistance to the same drugs in
.</description><subject>Antitubercular Agents</subject><subject>Mycobacterium kansasii</subject><subject>Mycobacterium tuberculosis</subject><subject>Susceptibility</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kU1v1DAQhi0Eokvhxhn5CBIpHieO4wvSagsFqRWIj7M1cZzFJbEX26m0_x6321b0wMnjmWfe0cxLyEtgJwC8e7deb04YyK6rQD4iK2Cqq1qh2sdkxVjbVk3HmiPyLKVLVv5CsafkiKumli2XK2JO47Kl35dk7C673k0u7-nXGMYS-S1FP9Az6212hp7abOPsPPqcaBjpTec3m1zK6I2lztOLvQk9msK5Zaa_0SdMzj0nT0ackn1x-x6Tnx8__Nh8qs6_nH3erM8rbKDL1aDADMBrlFyMIPqeN2IYkJlONoyPPesVCihJCyCF7ZRsjWhbUUvbDyjG-pi8P-juln62g7E-R5z0LroZ414HdPphxbtfehuutFBQK86LwOtbgRj-LDZlPbtymGlCb8OSNGeMc2CslgV9e0BNDClFO96PAaavfdHFF33ji4Zr_M0BxzRzfRmW6Msl_se--neNe-E70-q_P1iW5g</recordid><startdate>20180401</startdate><enddate>20180401</enddate><creator>Bakuła, Zofia</creator><creator>Modrzejewska, Magdalena</creator><creator>Pennings, Lian</creator><creator>Proboszcz, Małgorzata</creator><creator>Safianowska, Aleksandra</creator><creator>Bielecki, Jacek</creator><creator>van Ingen, Jakko</creator><creator>Jagielski, Tomasz</creator><general>American Society for Microbiology</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3343-6823</orcidid><orcidid>https://orcid.org/0000-0002-0581-2003</orcidid></search><sort><creationdate>20180401</creationdate><title>Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii</title><author>Bakuła, Zofia ; Modrzejewska, Magdalena ; Pennings, Lian ; Proboszcz, Małgorzata ; Safianowska, Aleksandra ; Bielecki, Jacek ; van Ingen, Jakko ; Jagielski, Tomasz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a418t-d91cd123a725f15bb245dda0c87402fb0b9a51245e1175e8976c566537ebda5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antitubercular Agents</topic><topic>Mycobacterium kansasii</topic><topic>Mycobacterium tuberculosis</topic><topic>Susceptibility</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bakuła, Zofia</creatorcontrib><creatorcontrib>Modrzejewska, Magdalena</creatorcontrib><creatorcontrib>Pennings, Lian</creatorcontrib><creatorcontrib>Proboszcz, Małgorzata</creatorcontrib><creatorcontrib>Safianowska, Aleksandra</creatorcontrib><creatorcontrib>Bielecki, Jacek</creatorcontrib><creatorcontrib>van Ingen, Jakko</creatorcontrib><creatorcontrib>Jagielski, Tomasz</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial agents and chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bakuła, Zofia</au><au>Modrzejewska, Magdalena</au><au>Pennings, Lian</au><au>Proboszcz, Małgorzata</au><au>Safianowska, Aleksandra</au><au>Bielecki, Jacek</au><au>van Ingen, Jakko</au><au>Jagielski, Tomasz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii</atitle><jtitle>Antimicrobial agents and chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2018-04-01</date><risdate>2018</risdate><volume>62</volume><issue>4</issue><issn>0066-4804</issn><eissn>1098-6596</eissn><abstract>Very few studies have examined drug susceptibility of
, and they involve a limited number of strains. The purpose of this study was to determine drug susceptibility profiles of
isolates representing a spectrum of species genotypes (subtypes) with two different methodologies, i.e., broth microdilution and Etest assays. To confirm drug resistance, drug target genes were sequenced. A collection of 85
isolates, including representatives of eight different subtypes (I to VI, I/II, and IIB) from eight countries, was used. Drug susceptibility against 13 and 8 antimycobacterial agents was tested by using broth microdilution and Etest, respectively. For drug-resistant or high-MIC isolates, eight structural genes (
,
,
,
,
,
,
, and
) and one regulatory region (
) were PCR amplified and sequenced in the search for resistance-associated mutations. All isolates tested were susceptible to rifampin (RIF), amikacin (AMK), co-trimoxazole (SXT), rifabutin (RFB), moxifloxacin (MXF), and linezolid (LZD) according to the microdilution method. Resistance to ethambutol (EMB), ciprofloxacin (CIP), and clarithromycin (CLR) was found in 83 (97.7%), 17 (20%), and 1 (1.2%) isolate, respectively. The calculated concordance between the Etest and dilution method was 22.6% for AMK, 4.8% for streptomycin (STR), 3.2% for CLR, and 1.6% for RIF. For EMB, INH, and SXT, not even a single MIC value determined by one method equaled that by the second method. The only mutations disclosed were A2266C transversion at the
gene (CLR-resistant strain) and A128G transition at the
gene (strain with STR MIC of >64 mg/liter). In conclusion, eight drugs, including RIF, CLR, AMK, SXT, RFB, MXF, LZD, and ethionamide (ETO), showed high
activity against
isolates. Discrepancies of the results between the reference microdilution method and Etest preclude the use of the latter for drug susceptibility determination in
Drug resistance in
may have different genetic determinants than resistance to the same drugs in
.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>29437627</pmid><doi>10.1128/AAC.01788-17</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-3343-6823</orcidid><orcidid>https://orcid.org/0000-0002-0581-2003</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0066-4804 |
ispartof | Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4) |
issn | 0066-4804 1098-6596 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5913922 |
source | PubMed Central Free; American Society for Microbiology Journals |
subjects | Antitubercular Agents Mycobacterium kansasii Mycobacterium tuberculosis Susceptibility |
title | Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T21%3A08%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug%20Susceptibility%20Profiling%20and%20Genetic%20Determinants%20of%20Drug%20Resistance%20in%20Mycobacterium%20kansasii&rft.jtitle=Antimicrobial%20agents%20and%20chemotherapy&rft.au=Baku%C5%82a,%20Zofia&rft.date=2018-04-01&rft.volume=62&rft.issue=4&rft.issn=0066-4804&rft.eissn=1098-6596&rft_id=info:doi/10.1128/AAC.01788-17&rft_dat=%3Cproquest_pubme%3E2002210037%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a418t-d91cd123a725f15bb245dda0c87402fb0b9a51245e1175e8976c566537ebda5f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2002210037&rft_id=info:pmid/29437627&rfr_iscdi=true |